Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3)
Open Access
- 1 January 2024
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 84, e278911
Abstract
The mutations of pncA gene encoding pyrazinamidase/PZase in Mycobacterium tuberculosis are often associated with pyrazinamide/PZA resistance. The H and R1 isolates showed significant phenotypic differences to PZA. The H isolate was PZA sensitive, but R1 was PZA resistant up to 100 ug/ml. The paper reports the pncA profile for both isolates and the activity of their protein expressed in Escherichia coli BL21(DE3). The 0.6 kb of each pncA genes have been subcloned successfully into the 5.4 kb pET30a vector and formed the pET30a-pncA recombinant with a size of 6.0 kb. The pncAR1 profile exhibited base mutations, but not for pncAH against to pncA from the PZA-sensitive M. tuberculosis H37RV published in Genbank ID: 888260. Three mutations were found in pncAR1, ie T41C, G419A, and A535G that subsequently changed amino acids of Cys14Arg, Arg140His and Ser179Gly in its protein level. The mutant PZase R1 that expressed as a 21 kDa protein in E. coli Bl21(DE3) lost 32% of its performance in activating PZA drug to pyrazinoic acid/POA compared to the wild-type PZase H. The mutation in the pncAR1 gene that followed by the decreasing of its PZase activity underlies the emergence of pyrazinamide resistance in the clinical isolate. Structural studies for the R1 mutant PZase protein should be further developed to reveal more precise drug resistance mechanisms and design more effective TB drugs.Keywords
This publication has 31 references indexed in Scilit:
- Immunogenicity assay of KatG protein from Mycobacterium tuberculosis in mice: preliminary screening of TB vaccineThe Ukrainian Biochemical Journal, 2018
- Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosisScientia Pharmaceutica, 2018
- Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosisInternational Journal of Mycobacteriology, 2018
- Structure - Activity Relationship of Mutant KatG from INH resistant Mycobacterium tuberculosisJournal of Pure and Applied Microbiology, 2017
- Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activationThe Ukrainian Biochemical Journal, 2016
- Role of Metal Ions on the Activity of Mycobacterium tuberculosis PyrazinamidaseThe American Journal of Tropical Medicine and Hygiene, 2012
- Novel mutations in katG gene of a clinical isolate of isoniazid-resistant Mycobacterium tuberculosisBiologia, 2012
- Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to PyrazinamidePLOS ONE, 2011
- Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidaseThe FEBS Journal, 2008
- Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillusNature Medicine, 1996